5280 Top Docs 2012 for Transplant Hepatology
5280 Magazine, in their 2012 Top Docs listing, says "Today progress is happening at an exponential rate. And many of Denver’s physicians—including the Top Docs profiled on the following pages—are at the forefront of new treatments, cutting-edge procedures, and promising research into how we can further heal an ailing heart.”
Congratulations James Burton, MD and Greg T. Everson, MD, FACP!
Sean Colgan, PhD, Director of Mucosal Inflammation Program receives Endowed Chair
With the vision and hard work of community leaders Jim Eichberg and Phil Karsh, as well as support from the CU Department of Medicine, the University of Colorado's Division of Gastroenterology and Hepatology was able to successfully establish the Levine- Kern Endowed Chair, which is currently held by Sean Colgan, PhD, Director of Mucosal Inflammation Program. The Chair is named after long-time gastroenterology clinical leader and School of Medicine Professor, Dr. Joel Levine and the late Dr. Fred Kern, School of Medicine Professor and head of the Gastroenterology Division at the University of Colorado.
Greg T. Everson, MD, FACP has written a new book
Dr. Everson says, “Hedy Weinberg and I wrote five editions of Living with Hepatitis C: A Survivor’s Guide for the purpose of providing patients and caregivers a resource that could serve as an authoritative readily-available resource. I provided the medical information and Hedy provided the patient perspective by interviewing many patients with HCV to provide a personal connection for the reader. In this new book, Curing Hepatitis C: Current and Future Options for Treatment, I have focused on issues and questions related to the current new standard of treatment, Triple Therapy, and the exciting emerging therapies. As treatment continues to improve, eradication of HCV infection will become increasingly common – the new paradigm will be living without, not with, hepatitis C. Perhaps I am overly optimistic, but I believe that it is entirely possible that the emerging treatments will be so potent and effective that nearly every patient with chronic hepatitis C may be cured by future antiviral therapies!”
Ken Berman, MD was awarded a grant from the VA Office of Rural Health to expand treatment to Veterans with HCV in rural settings with the use a virtual consult model.